You are leaving our website

You have clicked on a link that will take you to a third-party website that Alliance Pharmaceuticals plc group (“Alliance”) is not responsible for.

Please read the following disclaimer and click “I agree” to proceed to the third-party website.

By clicking to continue you agree that:You are leaving Alliance`s website.

Alliance:

  • Is not responsible for the content or accuracy of the third-party website nor endorse or guarantee any services or information they may offer.
  • Does not represent either the third-party website or you (the visitor) if you enter into an agreement or transaction.
  • Privacy and security policies do not apply to third-party websites.
or Decline

Significant Shareholders

Shares in Issue: 530,412,678 1p Ordinary Shares

Last updated: 19th November 2021

Significant Shareholders

Amount

% Holding

Fidelity Management & Research

53,600,055

9.98

Slater Investment

48,906,041

9.10

Kempen Capital Management

39,173,000

7.29

BlackRock Investment Management

28,391,678

5.29

Investec Group

23,674,295

4.41

Polar Capital

20,040,270

3.73

Rathbone plc

19,568,454

3.64

John Dawson

17,558,284

3.27

Shareholdings of Directors & their families

Amount

% Holding

Peter Butterfield

442,104

0.08

David Cook

234,129

0.04

Andrew Franklin

128,384

0.02

Richard Jones

15,000

0.00